Explore more publications!
North Dakota Healthcare Newswire
Got News to Share?

North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 21, 2026

At MD&M West 2026, TekniPlex Healthcare to Showcase Integrated MedTech CDMO and Sustainable Materials Science Solutions
January 21, 2026

At MD&M West 2026, TekniPlex Healthcare to Showcase Integrated MedTech CDMO and Sustainable Materials Science Solutions

Indeterminate GlobeNewswire
Manhattan Wellness Joins Lumina Therapy Alliance, Expanding the Nation’s Premier In-Person Mental Health Network
January 21, 2026

Manhattan Wellness Joins Lumina Therapy Alliance, Expanding the Nation’s Premier In-Person Mental Health Network

Indeterminate GlobeNewswire
Redefining Real-World Evidence: John Snow Labs Introduces First FDA-Ready Patient Journey Platform
January 21, 2026

Redefining Real-World Evidence: John Snow Labs Introduces First FDA-Ready Patient Journey Platform

Indeterminate GlobeNewswire
Dental Expert Dr. Marvin Chan Explains Missing Tooth Replacement for HelloNation
January 21, 2026

Dental Expert Dr. Marvin Chan Explains Missing Tooth Replacement for HelloNation

Indeterminate GlobeNewswire
PerfectServe is Furthest in Vision and Highest in Execution in 2026 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration
January 21, 2026

PerfectServe is Furthest in Vision and Highest in Execution in 2026 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration

Indeterminate GlobeNewswire
LiveWorld Announces Human-Led, AI-Powered Strategy & 2026 Solutions Roadmap
January 21, 2026

LiveWorld Announces Human-Led, AI-Powered Strategy & 2026 Solutions Roadmap

Indeterminate GlobeNewswire
Human Continuum Appoints Dr. Tsun “Sean” Law MD, MBA as its Chief Executive Officer to Lead the Research and Development Efforts Focused on Next-Generation Exosome Therapies and Over-the-Counter Exosome-based Products
January 21, 2026

Human Continuum Appoints Dr. Tsun “Sean” Law MD, MBA as its Chief Executive Officer to Lead the Research and Development Efforts Focused on Next-Generation Exosome Therapies and Over-the-Counter Exosome-based Products

Indeterminate GlobeNewswire
Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders
January 21, 2026

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders

Indeterminate GlobeNewswire
Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers
January 21, 2026

Actuate Therapeutics Announces Plans to Expand Clinical Pipeline, Advancing Elraglusib Tablet into a Phase 1/2 Clinical Program in Refractory Cancers

Indeterminate GlobeNewswire
Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock
January 21, 2026

Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock

Indeterminate GlobeNewswire
Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook
January 21, 2026

Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook

Indeterminate GlobeNewswire
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
January 21, 2026

Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit

Indeterminate GlobeNewswire
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
January 21, 2026

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA For Pilavapadin in the Treatment of Diabetic Peripheral Neuropathic Pain
January 21, 2026

Lexicon Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA For Pilavapadin in the Treatment of Diabetic Peripheral Neuropathic Pain

Indeterminate GlobeNewswire
NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts
January 21, 2026

NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

Indeterminate GlobeNewswire
Carboxymethyl Cellulose Market worth $5.04 billion by 2030 at 8.9%, says MarketsandMarkets™
January 21, 2026

Carboxymethyl Cellulose Market worth $5.04 billion by 2030 at 8.9%, says MarketsandMarkets™

Indeterminate GlobeNewswire
AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast
January 21, 2026

AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast

Indeterminate GlobeNewswire
Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)
January 21, 2026

Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)

Indeterminate GlobeNewswire
American Heart Association and Centre for Neuro Skills Deepen Relationship to Advance Stroke and Brain Injury Care
January 21, 2026

American Heart Association and Centre for Neuro Skills Deepen Relationship to Advance Stroke and Brain Injury Care

Indeterminate GlobeNewswire
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)
January 21, 2026

Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions